tiprankstipranks
Trending News
More News >

Vanguard Group Reduces Stake in Clarity Pharmaceuticals

Story Highlights
Vanguard Group Reduces Stake in Clarity Pharmaceuticals

Confident Investing Starts Here:

The latest announcement is out from Clarity Pharmaceuticals Ltd. ( (AU:CU6) ).

Clarity Pharmaceuticals Ltd. has announced that Vanguard Group, a significant shareholder, has ceased to be a substantial holder in the company as of May 30, 2025. This change in Vanguard Group’s holding reduces its voting power to 4.840%, potentially impacting Clarity Pharmaceuticals’ shareholder dynamics and market perception.

The most recent analyst rating on (AU:CU6) stock is a Buy with a A$6.10 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.

More about Clarity Pharmaceuticals Ltd.

Average Trading Volume: 2,894,035

Technical Sentiment Signal: Sell

Current Market Cap: A$609M

For a thorough assessment of CU6 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App